Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 8/20 | 0.46 |
| ▸ | CES1 | P23141 | 5/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10477763 | 1.00 | FFAR1 (0.46) | FFAR1FFAR4FAAHCES1CES2 | |
| SCHEMBL27942233 | 1.00 | FFAR1 (0.46) | FFAR1FFAR4FAAHCES1CES2 | |
| SCHEMBL27166294 | 1.00 | FFAR1 (0.46) | FFAR1FFAR4FAAHCES1CES2 | |
| SCHEMBL27611144 | 0.91 | FAAH (0.54) | FFAR1FFAR4FAAHCES1MEN1 | |
| SCHEMBL3107491 | 0.91 | FAAH (0.54) | FFAR1FFAR4FAAHCES1MEN1 | |
| SCHEMBL8603198 | 0.81 | FAAH (0.50) | FFAR1FFAR4FAAHCES1CES2 | |
| SCHEMBL6437298 | 0.80 | FFAR4 (0.44) | FFAR1FFAR4FAAHCES1CES2 | |
| SCHEMBL8048379 | 0.80 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL8054701 | 0.80 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL8384533 | 0.80 | FAAH (0.46) | FAAHCES1CES2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110478495-A | Target conjugate and its particle and preparation | TARVEDA THERAPEUTICS INC | 2019-11-22 | — | — | CN | disclosed |
| CN-110072883-A | The relevant peptide of therapeutic MOTS-C | 科巴公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-106573077-B | Targeted conjugates and particles and formulations thereof | 塔弗达治疗有限公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-104936622-A | Targeted conjugates encapsulated in particles and formulations thereof | BLEND THERAPEUTICS INC | 2015-09-23 | — | — | CN | disclosed |
| EP-0762899-A4 | STABILIZED HOMOGENOUS SUSPENSIONS AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 1999-08-18 | — | — | EP | disclosed |
| EP-0762899-A1 | STABILIZED HOMOGENOUS SUSPENSIONS AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1997-03-19 | — | — | EP | disclosed |
| WO-1995032005-A1 | STABILIZED HOMOGENOUS SUSPENSIONS AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1995-11-30 | — | — | WO | disclosed |